Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seenin 1978 and 1995 in Malmö, Sweden

Rheumatology

Volumn 48, Issue 12, 2009, Pages 1600-1605

  Bergström, Ulf ^a   Jacobsson, Lennart T H ^a   Turesson, Carl ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular; Disability evaluation; Disease activity; DMARDs; Epidemiology; Malm ; Morbidity; Mortality; Rheumatoid arthritis; Sweden

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIMALARIAL AGENT; ANTITHROMBOCYTIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISABILITY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE REGISTRY; DISEASE SEVERITY; FATALITY; FEMALE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; OUTPATIENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SWEDEN;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SWEDEN;

EID: 75649127199     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep301     Document Type: Article

References (53)

1. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995;22:1065-7.
2. Jacobsson LTH, Knowler WC, Pillemer S et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993;36:1045-53.
3. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149-53.
4. Solomon DH, Karlson EW, Rimm EB et al. Cardiovascular morbidity and mortality in women diagnosed with RA. Circulation 2003;107:1303-7.
5. Uhlig T, Kvien TK, Glennås A, Smedstad LM, Förre O. The incidence and severity of RA, results from a county register in Oslo, Norway. J Rheumatol 1998;25:1078-84.
6. Simonsson M, Bergman S, Jacobsson LTH, Petersson IF, Svensson B. The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol 1999;28:340-3.
7. Doran MF, Pond GR, Crowson CS, O'Fallon WM, Gabriel SE. Trends in incidence and mortality in RA in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002;46:625-31.
8. Kaipiainen-Seppänen O, Aho K, Isomäki H, Laakso M. Incidence of rheumatoid arthritis in Finland during 1980-1990. Ann Rheum Dis 1996;55:608-11.
9. Kaipiainen-Seppänen O, Aho K, Isomäki H, Laakso M. Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol 1996;14:537-42.
10. Kaipiainen-Seppanen O, Kautiainen H. Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000. J Rheumatol 2006;33: 2132-8.
11. Söderlin MK, Lindroth Y, Jacobsson LTH. Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden. Rheumatology 2007;46:1355-8.
12. Bergström U, Book C, Lindroth Y, Marsal L, Saxne T, Jacobsson LTH. Lower disease activity and disability in Swedish patients with RA in 1995 compared with 1978. Scand J Rheumatol 1999;28:160-5.
13. Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52:1009-19.
14. Heiberg T, Finset A, Uhlig T, Kvien TK. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:191-5.
15. Krause D, Schleusser B, Herborn G, Rau R. Response to methotrexate is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000;43:14-21.
16. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002;359:1173-7.
17. Gonzalez A, Maradit Kremers H, Crowson CS et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007;56:3583-7.
18. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26(5 Suppl. 5):S35-61.
19. Book C, Saxne T, Jacobsson LTH. Prediction of mortality in rheumatoid arthritis based on disease activity markers. J Rheumatol 2005;32:430-4.
20. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
21. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 2004;63:952-5.
23. Jacobsson L, Lindroth Y, Marsal L, Tejler L. The Malmo model for private and public rheumatological outpatient care. Cooperation makes it possible to introduce disease modifying treatment quickly. Lakartidningen 2001;98:4710-6.
24. Ritchie DM, Boyle JA, McInnes JM et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with RA. Q J Med 1968;37:393-406.
25. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in RA. J Am Med Assoc 1949;140:659-62.
26. Bozicevich J, Bunim JJ, Freund J, Ward SB. Bentonite flocculation test for rheumatoid arthritis. Proc Soc Exp Biol Med 1958;97:180-3.
27. The Center for Epidemiology at the Swedish National Board of Health, & Welfare. Xwww.socialstyrelsen.se/en/about/epc/Welcome+to.htmX. 2009 (4 September 2009, date last accessed).
28. World Health Organization. Manual of the International Classification of Diseases (ICD-8). Geneva: World Health Organization, 1967.
29. World Health Organization. International Classification of Diseases. Manual of the international statistical classification of diseases, injuries, and causes of death: based on the recommendations of the Ninth Revision Conference, 1975, and adopted by the Twenty-ninth World Health Assembly. Geneva: World Health Organization, 1977.
30. World Health Organization. International statistical classifications of diseases and related health problems. Geneva: World Health Organization, 1994.
31. Sundman L, Jakobsson S, Nyström L, Rosén M. A validation of cause of death certification for ischaemic heart disease in two Swedish municipalities. Scand J Prim Health Care 1988;6:205-11.
32. Krishnan E, Lingala VB, Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004;110:1774-9.
33. Young A, Koduri G, Batley M et al. Early Rheumatoid Arthritis Study (ERAS) group. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 2007;46:350-7.
34. Ward MM. Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? Arthritis Rheum 2001;44: 1467-69.
35. Silman A, Davies P, Currey HL, Evans SJ. Is RA becoming less severe? J Chron Dis 1983;36:891-7.
36. Aho K, Tuomi T, Palosuo T, Kaarela K, von Essen R, Isomäki H. Is seropositive RA becoming less severe? Clin Exp Rheumatol 1989;7:287-90.
37. Spector TD, Hart DJ, Powell RJ. Prevalence of RA and rheumatoid factor in women: evidence for a secular decline. Ann Rheum Dis 1993;52:254-7.
38. Silman AJ. Trends in the incidence and severity of rheumatoid arthritis. J Rheumatol 1992;32(Suppl. 32):71-3.
39. Jacobsson LTH, Hanson RL, Knowler WC et al. Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum 1994;37:1158-65.
40. van Dongen H, van Aken J, Lard LR et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebocontrolled trial. Arthritis Rheum 2007;56:1424-32.
41. Söderlin MK, Lindroth Y, Turesson C, Jacobsson LTH. More active treatment approach has profound effects on the long term disease course and health status of RA patients. Results from the Malmö (Sweden) RA cohort 1997-2005. Abstract SAT0147, EULAR, Paris, 2008.
42. Petri M. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 1996;5(Suppl. 1):S16-22.
43. Jacobsson LTH, Turesson C, Gülfe A et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005;32:1213-18.
44. Dixon WG, Watson KD, Lunt M, Hyrich KL (British Society for Rheumatology Biologics Register Control Centre Consortium). Silman AJ, Symmons DP. (British Society for Rheumatology Biologics Register). Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to antitumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007;56:2905-12.
45. Turesson C, Matteson EL. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases (Review). Curr Opin Rheumatol 2007;19:190-6.
46. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 1999;38:668-74.
47. Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562-71.
48. del Rincacón I, Freeman GL, Haas RW, O'Leary DH, Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005;52:3413-23.
49. Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW. Cardiovascular risk factors in woman with and without RA. Arthritis Rheum 2004;50:3444-9.
50. Jacobsson LTH, Lindgärde F, Manthorpe R, Åkesson B. Correlation of fatty acid composition of adipose tissue lipids and serum phosphatidylcholine and serum concentrations of micronutrients with disease duration in rheumatoid arthritis. Ann Rheum Dis 1990;49:901-5.
51. Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time of course of risk. Arthritis Rheum 2006;54:1378-89.
52. Bergström U, Jacobsson LTH, Nilsson JÅ, Berglund G, Turesson C. Smoking, but not pulmonary dysfunction predicts RA. A case-control study. Arthritis Rheum 2006; 54:S184-5.
53. Symmons DP, Bankhead CR, Harrison BJ et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997;40:1955-6.